L. Salmerón-Godoy , C. Arévalo-Cañas , M. Díaz-Santiáñez , C. Sánchez-Díaz , A. Muñoz-Blanco
{"title":"炎症性Miopatías","authors":"L. Salmerón-Godoy , C. Arévalo-Cañas , M. Díaz-Santiáñez , C. Sánchez-Díaz , A. Muñoz-Blanco","doi":"10.1016/j.med.2025.04.019","DOIUrl":null,"url":null,"abstract":"<div><div>Inflammatory myopathies (IM) are a heterogeneous group of acquired diseases of an autoimmune pathogenesis. They are classified into dermatomyositis (DM), polymyositis (PM), antisynthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), inclusion body myopathy (IBM), and myopathies associated with other systemic autoimmune diseases (SAD). They are multisystemic diseases with cutaneous, muscular, pulmonary, gastrointestinal, and cardiac involvement, among others. They may be associated with other SADs and neoplasms. Treatment is based on corticosteroids associated with immunosuppressants. The prognosis depends on treatment response and clinical compromise.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 31","pages":"Pages 1849-1860"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Miopatías inflamatorias\",\"authors\":\"L. Salmerón-Godoy , C. Arévalo-Cañas , M. Díaz-Santiáñez , C. Sánchez-Díaz , A. Muñoz-Blanco\",\"doi\":\"10.1016/j.med.2025.04.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Inflammatory myopathies (IM) are a heterogeneous group of acquired diseases of an autoimmune pathogenesis. They are classified into dermatomyositis (DM), polymyositis (PM), antisynthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), inclusion body myopathy (IBM), and myopathies associated with other systemic autoimmune diseases (SAD). They are multisystemic diseases with cutaneous, muscular, pulmonary, gastrointestinal, and cardiac involvement, among others. They may be associated with other SADs and neoplasms. Treatment is based on corticosteroids associated with immunosuppressants. The prognosis depends on treatment response and clinical compromise.</div></div>\",\"PeriodicalId\":100912,\"journal\":{\"name\":\"Medicine - Programa de Formación Médica Continuada Acreditado\",\"volume\":\"14 31\",\"pages\":\"Pages 1849-1860\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine - Programa de Formación Médica Continuada Acreditado\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304541225000927\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225000927","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Inflammatory myopathies (IM) are a heterogeneous group of acquired diseases of an autoimmune pathogenesis. They are classified into dermatomyositis (DM), polymyositis (PM), antisynthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), inclusion body myopathy (IBM), and myopathies associated with other systemic autoimmune diseases (SAD). They are multisystemic diseases with cutaneous, muscular, pulmonary, gastrointestinal, and cardiac involvement, among others. They may be associated with other SADs and neoplasms. Treatment is based on corticosteroids associated with immunosuppressants. The prognosis depends on treatment response and clinical compromise.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
